Univitamin: The company sells fenugreek as a biochemical reagent and is used in the research stage_Oriental Fortune Network

Some investors asked questions on the investor interaction platform:Junshi BiologyVV116 is a remdesivir derivative in terms of molecular structure, and the anti-new coronavirus effect of fenugreek is 7.7 times that of remdesivir. As a supplier of upstream reagents for life sciences and a rare listed company of fenugreek in China, your company can take advantage of the first-mover advantage and integrate the industrial chain of fenugreek with relevant parties (upstream planting, midstream extraction, downstream animal testing, and even late-stage clinical trials). and marketing) to contribute to the global fight against the epidemic. Suggestions: 1. The company optimizes the plant extraction process or chemical synthesis route of fenugreek; 2. The company participates in the scientific research of fenugreek against the new coronavirus: animal tests and clinical trials.

　　Unionway(301166.SZ) said on the investor interactive platform on May 18 that the fenugreek sold by our company is used as a biochemical reagent in the research stage. This product is an ODM product of the company’s subsidiary Aibixin, not a self-produced product. In the future, the company will be based on the brand image of antibody experts, focus on antibodies and antibody-related reagents, and introduce more products and equipment through self-research and introduction of third-party brands, and continue to enhance the company’s one-stop service capability for life sciences.

(Article source: Daily Economic News)

Article source: Daily Economic News

Responsible editor: 73

Original title: Univitamin: The company sells fenugreek as a biochemical reagent, which is used in the research stage